Meningococcal Vaccine Market Driven by Increasing Demand in Developing Countries | Registering a CAGR of 9.5% from 2019 to 2026. 

As per the report published by Allied Market Research, the global Meningococcal Vaccine Industry garnered $1.93 billion in 2018, and is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions. Key Takeaways: Asia-Pacific region is …